The impact of a lumping versus splitting strategy to the headache history on accurate diagnosis of chronic migraine

被引：0
|
作者：
Yadav, P. [1 ]
Smith, J. H. [2 ]
机构：
[1] Univ Kentucky, Lexington, KY USA
[2] Univ Kentucky, Coll Med, Lexington, KY USA
来源：
HEADACHE | 2016年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PF51
引用
收藏
页码：39 / 39
页数：1
相关论文
共 50 条
  • [31] Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial
    Schwedt, Todd J.
    Hentz, Joseph G.
    Sahai-Srivastava, Soma
    Spare, Nicole M.
    Martin, Vincent T.
    Treppendahl, Christina
    Digre, Kathleen
    Bennett, Nathan L.
    Birlea, Marius
    Watson, David
    Murinova, Natalia
    Robert, Teri
    Dodick, David W.
    HEADACHE, 2021, 61 (02): : 351 - 362
  • [32] Comparison of validity and reliability of the Migraine disability assessment (MIDAS) versus headache impact test (HIT) in an Iranian population
    Ghorbani, Abbas
    Chitsaz, Ahmad
    IRANIAN JOURNAL OF NEUROLOGY, 2011, 10 (3-4) : 39 - 42
  • [33] Medical Consultation and Headache-Impact among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Manack, Aubrey N.
    Buse, Dawn C.
    Serrano, Daniel
    Varon, Sepideh F.
    Turkel, Catherine C.
    Lipton, Richard B.
    ANNALS OF NEUROLOGY, 2011, 70 : S62 - S63
  • [34] Medical Consultation and Headache-Impact among Persons with Chronic Migraine (CM) and Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Manack, A. N.
    Buse, D. C.
    Serrano, D.
    Reed, M. L.
    Turkel, C. C.
    Lipton, R. B.
    HEADACHE, 2011, 51 : 33 - 33
  • [35] The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
    Silberstein, Stephen D.
    Diener, Hans-Christoph
    Dodick, David W.
    Manack Adams, Aubrey
    DeGryse, Ronald E.
    Lipton, Richard B.
    PAIN AND THERAPY, 2020, 9 (02) : 695 - 707
  • [36] The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
    Stephen D. Silberstein
    Hans-Christoph Diener
    David W. Dodick
    Aubrey Manack Adams
    Ronald E. DeGryse
    Richard B. Lipton
    Pain and Therapy, 2020, 9 : 695 - 707
  • [37] COMMON MIGRAINE VERSUS DAILY CHRONIC HEADACHE - A STUDY OF THE RELATIONSHIP BETWEEN DEPRESSION AND ANXIETY SCORES, AND DEXAMETHASONE SUPPRESSION TEST
    FALASCHI, P
    CERBO, R
    DICESARE, G
    CUSIMANO, G
    IELLAMO, R
    FORMISANO, R
    AGNOLI, A
    CEPHALALGIA, 1985, 5 : 215 - 217
  • [38] Inpatient infusion treatments of headache in patients with chronic migraine and a reported history of head trauma and endocrine co-morbidities
    Riggins, Nina Yakovlevna
    Sawhney, Henna
    Ehrlich, Annika
    Parekh, Mira
    Levin, Morris
    NEUROLOGY, 2020, 95 : S14 - S14
  • [39] Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study
    Houts, Carrie R.
    McGinley, James S.
    Wirth, R. J.
    Cady, Roger
    Lipton, Richard B.
    QUALITY OF LIFE RESEARCH, 2021, 30 (03) : 931 - 943
  • [40] Reliability and validity of the 6-item Headache Impact Test in chronic migraine from the PROMISE-2 study
    Carrie R. Houts
    James S. McGinley
    R. J. Wirth
    Roger Cady
    Richard B. Lipton
    Quality of Life Research, 2021, 30 : 931 - 943
12345